发明名称 anticorpo biespecífico, composição farmacêutica, uso, método de tratamento de um paciente que sofre de câncer e de um paciente que sofre de inflamação
摘要 The current invention relates to bispecific antibodies wherein the binding affinity to one of the two antigens is reduced and which can be activated by tumor- or inflammation-specific proteases, and the preparation and use of such bispecific antibodies.
申请公布号 BR112013002167(A2) 申请公布日期 2016.05.31
申请号 BR20131102167 申请日期 2011.08.23
申请人 ROCHE GLYCART AG 发明人 CLAUDIO SUSTMANN;JUERGEN MICHAEL SCHANZER;PABLO UMANA;REBECCA CROASDALE;SILKE METZ;ULRICH BRINKMANN
分类号 C07K16/00;C07K16/28;C07K16/32 主分类号 C07K16/00
代理机构 代理人
主权项
地址